all report title image
  • Published On : May 2022
  • Code : CMI2155
  • Industry : Food Ingredients
  • Pages : 100
  • Formats :

Bacillus coagulans is a bacteria utilized as a probiotic. The bacteria’s ability to withstand harsh acidic environments has led to its adoption in probiotics, which specifically target the human digestive system. It is useful in alleviating stomach ailments, constipation, flatulence, abdominal pain, and irritable bowel syndrome. Due to the bacteria’s efficacious properties, it finds application in both human and animal nutrition. Other beneficial properties include improved immunity, prevention of respiratory disorders, and anti-carcinogenic agents.

The global bacillus coagulans market is estimated to surpass US$ 1057.1 million by the end of 2028 in terms of revenue, exhibiting a CAGR of 7.91% during the forecast period (2021 to 2028).

Drivers

Bacillus coagulans market is witnessing growing demand in the cosmetic industry, owing to the immense benefits offered in managing acne and skin problems. New formulations including Bacillus coagulans are being launched by cosmetics providers for anti-aging effects. These products include face masks, lotion, scrub, gel, creams, and cleansers. Cosmetics product manufacturers are also focusing on developing cosmeceutical ingredients including bacillus coagulans to be used in various cosmetic products including cream, lotion, powder, and others. Bacillus coagulans are also gaining popularity in treating and managing symptoms of atopic dermatitis and eczema. Its incorporation in cosmetic products including anti-acne face wash and moisturizing cream is also on a rise. Owing to its biological activity and protection of skin, bacillus coagulans are widely used in personal care products.

The emerging economies of ASEAN, China, and India are expected to be the key markets for bacillus coagulans, as these are the major consumers of functional food and beverages. Moreover, increasing geriatric population in these economies is one of the major factors driving growth of the market.

Among regions, Asia Pacific held the largest revenue share of 55.7% in the global bacillus coagulans market in 2020.  The region is also projected to be the fastest growing with a CAGR of over the forecast period. This can be attributed to rising healthcare spending by the populace in the region. to the in South East Asia, the healthcare spending in ASEAN countries was estimated to be around US$ 182 billion, in 2019.

Figure 1. Global Bacillus Coagulans Market Revenue Share (%), By Region, 2020

Bacillus Coagulans  | Coherent Market Insights

Market Restraints

Side-effects of Bacillus coagulans is very mild but carelessness in dosage can result in intestinal gas and bloating. There is an ongoing debate on potential risk and side-effects of bacillus coagulans because it is not naturally present in the digestive system. Various strains of bacillus coagulans have been identified that may not be safe to use as probiotics. While bacillus coagulans may offer several benefits as compared to other probiotics, the research done on these probiotics is still limited. There is also a concern that spores produced by bacillus coagulans can move out of the digestive tract and reach other parts. Hence, it is not recommended for people with immunocompromised conditions, or the person using a catheter as it may lead to bacterial infection.

CMI table icon

Bacillus Coagulans Market Report Coverage

Report Coverage Details
Base Year: 2020 Market Size in 2021: US$ 620.4 Mn
Historical Data for: 2017, 2018, and 2019 Forecast Period: 2021 to 2028
Forecast Period 2020 to 2027 CAGR: 7.91% 2028 Value Projection: US$ 1057.1 Mn
Geographies covered:
  • Region: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa
Segments covered:
  • By Application: Bakery Products, Confectionary, Dairy Products, Beverages, Functional Food, Animal Feed
Companies covered:

Ganeden, Sabinsa Corporation, UAS Laboratories, Sanzyme, Mitsubishi Chemical Foods Corporation, Mystical Biotech Pvt. Ltd., Aumgene Biosciences, Unique Biotech Ltd., Nebraska Culture, and Syngem Biotech

Growth Drivers:
  • Increasing geriatric population in ASEAN, China, and India are expected to be the key markets for bacillus coagulans, as these are major consumers of functional food and beverages
  • Cosmetic industry rapidly adopting bacillus coagulans
Restraints & Challenges:
  • Limited research and potential health risk such as stomach ailments, constipation, flatulence, abdominal pain, and irritable bowel syndrome. pose a unique market challenge

Market Trends

Wellness and health continue to be at the forefront of new product development strategies with new dairy-free probiotic foods hitting the market each year. Bacillus coagulans are emerging as the main ingredient in the majority of dairy-free food. There has been an increased in demand for non-dairy probiotics, owing to the rise in the vegetarian and vegan desire for low milk cholesterol and increased lactose intolerance. Reported safe by the US food and drug administration and European Food Safety Authority , bacillus coagulans are largely added in dairy-free probiotic supplements and functional food products. The high stability of bacillus coagulans through heating and processing is leading to the growing demand for heat-treated food products. Most of the products used in the food industry that can be produced by Bacillus coagulans are gaining popularity due to the alternative to other harmful chemical sources such as guar gum, artificial sweeteners, etc.

Figure 2. Global Bacillus Coagulans Market Revenue Share (%), By Application, 2020

Bacillus Coagulans  | Coherent Market Insights

On the basis of application, in 2020, functional food segment held largest revenue share of 36.9% in the global bacillus coagulans market. The segment is expected to be the largest and the fastest growing over the forecast period. Functional food such as breakfast cereals, gels, bars, and gummies are popular products infused with bacillus coagulans. Dairy products, sports beverages, and baked goods are also popular applications of bacillus coagulans. The bacteria in bacillus coagulans is highly stable at high temperatures and is viable during high temperature processes such as baking.

Global Bacillus Coagulans Market - Impact of Coronavirus (COVID-19) Pandemic

In recent COVID-19 outbreak, the operations of numerous industries have either been temporarily halted or are functioning with a minimal workforce due to enforced lockdowns and imposed restrictions by respective governing bodies. The global bacillus coagulans market is no different, and this factor is expected to have a significantly negative impact on the revenue growth of this industry. The ongoing COVID-19 pandemic has changed the eating and drinking habits of people. People have become more conscious about the food they have been consuming on a day-to-day basis. Moreover, there is an increasing demand for pure and natural ingredients in probiotic products which has led the key players in the market to expand their product offerings with an extensive range of authentic fruit-based probiotic products.

Competitive Section

Major players operating in the global bacillus coagulans market include Ganeden, Sabinsa Corporation, UAS Laboratories, Sanzyme, Mitsubishi Chemical Foods Corporation, Mystical Biotech Pvt. Ltd., Aumgene Biosciences, Unique Biotech Ltd., Nebraska Culture, and Syngem Biotech

Bacillus coagulans is a spore-forming bacterium, which is largely utilized for its probiotic nature. The bacterium on consumption is known to improve gut health and slow the onset of stomach and digestive disorders. The bacterium finds application in products such as bakery, confectionery, dairy, beverages, functional food, and animal feed. Bacillus coagulans, earlier known as lactobacillus sporogenes and generally termed as Lactic Acid Bacteria is a gram-positive, spore-forming bacterium used as a probiotic. Bacillus coagulans is non-pathogenic and beneficial for human consumption. It is used in various therapeutic treatments such as diarrhea, constipation, digestive problems, lactose intolerance, and immunity enhancement.

Market Dynamics

Bacillus coagulans market is witnessing a growing demand in the cosmetic industry, owing to the immense benefits offered in managing skin problems and acne. New formulations including bacillus coagulans are being launched by cosmetics providers for anti-aging effects.

Significant advancements in the probiotics industry is expected to drive growth of the global bacillus coagulans market. Increasing prevalence of obesity and non-communicable diseases are significant factors contributing to the market growth. Increasing consumer awareness regarding health and diseases in emerging economies of Asia Pacific has led to rising demand for healthcare products such as probiotics, supplements, and functional food. Moreover, industry spending on research & development of new probiotics products has led to the launch of various new products, which has opened up various new market avenues for manufacturers to target. However, stringent government regulations for the approval of probiotics may hinder growth of the bacillus coagulans market. The efforts by companies to represent probiotics in different attractive formulations such as bars, yogurt, and chewing tablets are expected to attract the population towards probiotics and prebiotic products, thereby driving the growth of the global bacillus coagulans market.

Key features of the study:

  • This report provides an in-depth analysis of global bacillus coagulans market, and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2021-2028), considering 2020 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global bacillus coagulans market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include Ganeden, Sabinsa Corporation, UAS Laboratories, Sanzyme, Mitsubishi Chemical Foods Corporation, Mystical Biotech Pvt. Ltd., Aumgene Biosciences, Unique Biotech Ltd, Nebraska Cultures, and Syngen Biotech
  • Insights from this report would allow marketers and management authorities of companies to make informed decision regarding future product launches, technology up gradation, market expansion, and marketing tactics
  • The global bacillus coagulans market report caters to various stakeholders in this industry including investors, suppliers, bacillus coagulans manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bacillus coagulans market

Detailed Segmentation:

  • Global Bacillus Coagulans Market, By Application:
    • Bakery Products
    • Confectionary
    • Dairy Products
    • Beverages
    • Functional Food
    • Animal Feed
  • Global Bacillus Coagulans Market, By Region:
    • North America
      • By Country:
        • U.S
        • Canada
    • Latin America
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Country:
        • Germany
        • U.K
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East & Africa
      • By Country/Region:
        • Middle East
        • Africa
  • Company Profiles
    • Ganeden
      • Company Overview
      • Product Portfolio
      • Key Strategies
      • Recent Developments
      • Future Plans
    • Sabinsa Corporation
    • UAS Laboratories
    • Sanzyme
    • Mitsubishi Chemical Foods Corporation
    • Mystical Biotech Pvt. Ltd.
    • Aumgene Biosciences
    • Unique Biotech Ltd.
    • Nebraska Culture
    • Syngem Biotech

“*” marked represents similar segmentation in other categories in the respective section.

Frequently Asked Questions

The global bacillus coagulans market is estimated to surpass US$ 1057.1 million by 2028 and is expected to exhibit a CAGR of 7.91% between 2021 and 2028.
Health benefits associated with the consumption of bacillus coagulans such as brain health & aging, gastrointestinal health, and cardio & heart health is one of the major factors that is expected to drive growth of the market over the forecast period.
Promising application in non-dairy food products is one of the key trend in the market.
Increasing number of cancer patients has receded the growth of the market.
Major players operating in the market include Ganeden, Sabinsa Corporation, UAS Laboratories, Sanzyme, Mitsubishi Chemical Foods Corporation, Mystical Biotech Pvt. Ltd., Aumgene Biosciences, Unique Biotech Ltd., Nebraska Culture, and Syngem Biotech
The market is estimated to be valued at US$ 620.4 million in terms of revenue in 2021.

Related Reports

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo